🔔Stock Alerts via Telegram — Free for All Users

CHEK Stock Risk & Deep Value Analysis

CHEK

DVR Score

0.5

out of 10

Distressed

What You Need to Know About CHEK Stock

We analyzed CHEK using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran CHEK through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated Apr 7, 2026Run Fresh Analysis →

CHEK Risk Analysis & Red Flags

What Could Go Wrong

The ticker CHEK represents a delisted and merged entity. Attempting to invest in it under this ticker would result in purchasing a defunct asset with no value or trading activity. The biggest risk is misunderstanding the ticker's status.

Risk Matrix

Overall

Aggressive

Financial

High

Market

High

Competitive

High

Execution

High

Regulatory

High

Red Flags

  • Company (Check-Cap Ltd.) is no longer an independent, publicly traded entity.

  • Ticker CHEK is delisted/merged as of March 2023.

  • No verifiable real-time market data or financials are available for CHEK.

  • The current price of $1.73 is likely a residual or misattributed price, as the stock is not actively trading.

Upcoming Risk Events

  • 📅

    Not applicable as the entity no longer exists and has no independent risk events.

When to Reconsider

  • 🚪

    Any attempt to buy shares under the CHEK ticker should be immediately reversed.

  • 🚪

    If misidentified as a current investment, liquidate any holdings linked to this defunct ticker.

Unlock CHEK Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

There is no investment thesis for Check-Cap Ltd. (CHEK) as it is a delisted and merged entity. The ticker no longer represents a viable investment opportunity with 10x growth potential, or any potential at all, as a standalone company.

Is CHEK Stock Undervalued?

Check-Cap Ltd. (CHEK) fundamentally ceased to exist as an independent growth vehicle following its merger with Gataca Health Inc. in March 2023. The combined entity now trades as GTCA, and the original CHEK ticker is delisted and no longer represents an active, tradable company with independent operations. The real-time market intelligence provided further corroborates this, showing 'no verifiable data' for Check-Cap Ltd. or any matching entity on requested metrics. Therefore, the likelihood of Check-Cap Ltd. achieving 10x growth as the specified entity is virtually zero due to its non-existence. The score remains consistent with the previous assessment, as no material changes have occurred to alter its status. Investing in CHEK as a standalone entity is impossible and would yield no return, classifying it as a complete dud.

Unlock the full AI analysis for CHEK

Get the complete DVR score, risk analysis, and more

CHEK Price Targets & Strategy

000

Valuation Basis

The company Check-Cap Ltd. (CHEK) no longer exists as an independent public entity. It was delisted/merged in March 2023, and the new entity trades under GTCA. Therefore, a valuation for CHEK is not applicable.

Entry Strategy

Not applicable as the entity no longer exists and is not traded under the CHEK ticker.

Exit Strategy

Not applicable as the entity no longer exists and is not traded under the CHEK ticker.

Portfolio Allocation

0% - This ticker represents a defunct entity and should not be allocated to any portfolio.

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Does CHEK Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

Not applicable; moat has completely eroded with the cessation of independent operations.

Moat Sources

1 Identified

Not applicable as the entity no longer exists.

The moat is non-existent as the company no longer operates independently under this ticker.

Moat Erosion Risks

  • Complete loss of independent operating status.
  • Merger and subsequent delisting.

CHEK Competitive Moat Analysis

Sign up to see competitive advantages

CHEK Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Bearish (due to non-existence as tradable entity)

Institutional Sentiment

Negative (no institutional coverage or interest for a defunct entity)

Insider Activity (Form 4)

Not applicable; no insider activity for a delisted/merged entity.

Options Flow

No active options chain for this ticker; normal activity due to non-existence.

Earnings Intelligence

Next Earnings

Not applicable; the entity no longer exists to report earnings.

Surprise Probability

Not applicable.

Historical Earnings Pattern

Not applicable.

Key Metrics to Watch

Not applicable.

Competitive Position

Top Competitor

Not applicable as the entity no longer exists.

Market Share Trend

Not applicable.

Valuation vs Peers

Not applicable.

Competitive Advantages

  • Not applicable as the entity no longer exists.

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive CHEK Stock Higher?

Near-Term (0-6 months)

  • Not applicable as the entity no longer exists and has no independent catalysts.

Medium-Term (6-18 months)

  • Not applicable as the entity no longer exists and has no independent catalysts.

Long-Term (18+ months)

  • Not applicable as the entity no longer exists and has no independent catalysts.

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for CHEK?

  • Confirmation that the ticker remains defunct and inactive.

  • Avoidance of any trading activity associated with this ticker.

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How CHEK Makes Money

Check-Cap Ltd. (CHEK) was historically a medical diagnostics company focused on developing a non-invasive, radiation-free capsule system for colorectal cancer screening. Its business model revolved around R&D, clinical trials, and seeking regulatory approval for its C-Scan system, with the ultimate goal of commercializing the device and generating revenue through sales or licensing. However, this business model ceased to be applicable to CHEK as an independent entity following its merger with Gataca Health Inc. in March 2023.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for CHEK (CHEK)?

As of April 7, 2026, CHEK has a DVR Score of 0.5 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the risk level for CHEK stock?

Our analysis rates CHEK's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

Is CHEK's revenue growing?

CHEK has reported revenue growth of 0.0%. Revenue has been declining, which warrants closer examination.

Is CHEK stock profitable?

CHEK has a profit margin of 0.0%. The company is currently unprofitable.

How often is the CHEK DVR analysis updated?

Our AI-powered analysis of CHEK is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 7, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CHEK (CHEK) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to CHEK Stock Risk & Deep Value Analysis